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Background: The involvement of hypercholesterolemia in cardiovascular disorders has been 
widely researched but the impact on the specific cardiovascular (CV) indices following 
remodeling and cardiac malfunction remain to be fully elucidated. The aim this research is 
intended to further the understanding of cardiovascular function under hypercholesterolemic 
condition in mammals and serve as a guide to pharmaceutical formulation and medical 
interventions. Methods: The telemetry technique was used to investigate the cardiovascular 
dysfunctions in induced hypercholesterolemia in Wistar Kyoto (WKY) rats. Methods for this 
investigation include: inducing hypercholesterolemic condition in Wistar Kyoto rats through 
diet; measuring the blood cholesterol levels of the experimental animals; measuring 
cardiovascular indices in conscious rats to establish vascular dysfunction and/or cardiac 
malfunction. Results: Our study showed that pulse pressure decreases in experimental WKY 
rats with increasing cholesterol content in the diet.  It also shows that diet related pulse 
pressure decrease occurs in both low and high animal activities. The pulse pressure was 
reduced at both low and high animal activities in the 2% cholesterol diet (N=6) when 
compared to control (N=4) and 1% cholesterol diet (N=7). All results presented were 
statistically significant at a P value < 0.05. Our study has shown that pulse pressure (PP) 
declined significantly in the 2% cholesterol loaded diet, but not in the 1% diet. We also 
observed that in overall, the 1% diet group maintained close to normal cardiovascular indices 
compared to the control and 2%. Conclusion: Our results show that a high cholesterol diet 
may have negatively impacted the cardiac function more than the vascular function. 
.   
 
INTRODUCTION1  
Hypercholesterolemia is a form of hyperlipidemia - 
excessive level of lipids in blood. Cholesterol is one of 
the most dreaded classes of lipids, principally because 
of its implication in atherosclerosis, coronary artery 
disease (CAD), and other cardiovascular disorders 
(Balakumar et al., 2007). In spite of this unsavory 
reputation for cholesterol, it is also acclaimed for its 
usefulness as a primary component of the most valued 
steroid hormones.  Hypercholesterolemia is a metabolic 
derangement that can be secondary to many diseases 
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and can contribute to many disease forms of most 
notably, cardiovascular diseases. This may be related to 
diet, genetic factors (familial hypercholesterolemia) 
and the presence of other diseases such as diabetes and 
under-active thyroid (Mozaffarian et al., 2006). The 
disorders associated with high levels of blood 
cholesterol (hypercholesterolemia - > 240 mg/dL or > 
6.2 mmol/L) have been widely researched, and their 
physiological/biochemical relevance have also been 
moderately reported.  The initial focus of researchers 
was to fully establish its involvement in many 
cardiovascular diseases.  
hypercholesterolemia often occurs in conjunction with 
other metabolic risk factors, including glucose 
intolerance, obesity, diabetes and metabolic syndromes 
(Rothad et al., 2011). Clinical trials show that lowering 
lipids reduce the morbidity and mortality associated 
with cardiovascular complication (Amundsen et al., 
2002). Consequently, several pharmaceutical 
compounds such as Lipitor, Crestor, Zocor, pravastatin 
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etc. have been formulated to control excess blood 
cholesterol.  Several researchers have equally reported 
on compounds of plant origins that showed 
hypolipidemic activity, including Punica granatum 
(flower extract) Mazhar Igbal et al., 2011; Bengal gram 
(cicer arietinum), Sharma 1999 Camphene, a plant-
derived Monoterpene, Villianou et al., 2011, and more. 
Currently, the focus has shifted to the effect of 
hypercholesterolemia in vascular dysfunction and the 
mechanistic pathways involved in the dysfunction. 
Hypercholesterolemia is a common risk factor for early 
atherosclerosis prior to the appearance of over 
atherosclerotic changes in the vascular wall; it induces 
vascular functional changes that may lead to local 
ischemia and vascular remodeling (Bentley et al., 
2002). Steinberg and Witztum (1999) reported that 
LDL oxidation, endothelial dysfunction and 
inflammation are involved in the pathogenesis of 
atherosclerosis. Therefore, the role of nitric oxide 
(NO/EDRF) and the free radicals in vascular health 
cannot be overemphasized. Free radicals have been 
reported to induce oxidation of lipids controlled by a 
wide spectrum of enzymatic antioxidants and non-
enzymatic antioxidants such as superoxide dismutase 
and glutathione peroxides (GSHPx), vitamin E and 
glutathione (Valko et al., 2007). Nitric oxide has also 
been widely reported as a central modulator of vascular 
damage. A number of intracellular effects leading to 
vascular relaxation, endothelial regeneration, reduction 
of oxidative mechanism, inhibition of leukocyte 
chemotaxis and platelet adhesion have been attributed 
to nitric oxide (Napoli et al. 2001). In understanding the 
mechanisms of vascular wall remodeling, it has been 
suggested that Protein Kinase N1 (PKN1) plays a 
critical role in vascular wall remodeling, and therefore, 
could be a promising new target for the next generation 
of drugs for vascular diseases, particularly restenosis 
following angioplasty, stent implantation or vein 
grafting (Nikhlesh et al., 2012). 
 
In light of the above overwhelming evidence, this study 
was aimed to investigate the possibility of identifying 
some dynamics in cardiovascular indices emanating 
from induced-hypercholesterolemia in Wistar Kyoto 
(WKY) rats. It has been reported that pulse pressure 
(PP) has evidently risen after the fifth decade of life, 
due to arterial stiffening with increasing age (Franklin 
et. al. 1997; Kelly et. al. 1989). Conversely, other 
studies involving patients with advanced heart failure, 
low PP was associated with high CV mortality rates 
(Aronson and Burger 2004; Petrie et al. 2009). Due to 
this controversy, the present study was designed to 
examine if the high cholesterol diet is capable of 
triggering low or high PP. 
 
MATERIALS AND METHODS 
Animals and experimental Design 
Animal selection and diet inducing hyper-
cholesterolemia  
 
The experiment was conducted, using animals that had 
the same date of birth and weaned on the same date, but 
grown to be a twelve-week-old or more before implant. 
The 36 females (or male) Wistar Kyoto rats (WKY) 
were acquired from the department of biological 
sciences, animal facility at Minnesota State University 
(MSU), Mankato, Minnesota, USA. The animals were 
divided into three groups. The group I was designated 
as a control group and groups II and III were fed on 
high cholesterol diet [diet item number TD.02331 and 
TD.82312 – manufactured by Halan Laboratories Inc., 
Indianapolis, USA]. The characteristics of the 
experimental diet Cholesterol-fed rats (groups II & III) 
were chow enriched with 1% and 2% (w/w) cholesterol 
for 12-week diet period respectively. The control 
(normal) group was fed on standard chow. The rats 
were maintained in groups in their individual cages, 
under controlled temperature, humidity, and 
illumination conditions, with water and diet ad libitum 
for twelve weeks (Matos et al., 2005). All animal 
protocols were performed in accordance with the 
relevant guidelines and regulations approved by the 
Institutional Animal Care and Use Committee 
(IACUC) of the Minnesota State University, Mankato, 
Minnesota, USA. 
 
Establishing the condition of elevated blood cholesterol 
level (hypercholesterolemia) – At the end of the 12-
week diet period (Csont et al., 2002), blood cholesterol 
levels were measured in the control and cholesterol-fed 
groups to ascertain that hypercholesterolemia condition 
does exist in the experimental animals. Abcam's HDL 
and LDL/VLDL Cholesterol Quantification Assay Kit 
(ab65390) was used for the measurement. The HDL 
and LDL/VLDL Cholesterol Quantification Kit provide 
a simple quantification method of HDL and 
LDL/VLDL after a convenient separation of HDL from 
LDL and VLDL (very low-density lipoprotein) in 
serum samples. In the assay, cholesterol oxidase 
specifically recognizes free cholesterol and produces 
products which react with probe to generate color (570 
nm) and fluorescence (Ex/Em = 538/587 nm). 
Cholesterol esterase hydrolyzes cholesteryl ester into 
free cholesterol, therefore, cholesterol ester and free 
cholesterol can be detected separately in the presence 
and absence of cholesterol esterase in the reactions. 
Reacts with: Mouse, Rat, Rabbit, and Human and 
predicted to work with: all Mammals (Hu P. et. al., 
2013 and Kuhla A. et. al., 2013) 
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Measuring Cardiovascular indices in conscious rats 
Various CV indices were measured in conscious 
hypercholestrolemic rats and a control group for 
vascular dysfunction. A smaller and lighter telemetry 
device was implanted through the femoral artery and 
extended into the abdominal aorta of rats, leading to the 
acquisition of stable and high-quality data, similar to 
those obtained by using a larger telemetry device 
developed for rats. The use of smaller transmitters 
represents an alternative telemetry technique, especially 
for those cases in which space in the abdominal cavity 
is particularly limited such as during pregnancy have 
been reported (Braga and Prabhakar 2009). Each 
implant was carried out under a standardized 
sterilization procedure, including hand washing with 
cholorohexidine and autoclaving of surgical equipment 
before each surgery. All animals were sedated with a 
mixture of isofluorane and oxygen gases in a ratio of 
3:1. The relatively tiny rat femoral artery was dilated 
with a perfusion of Lidocaine Hydrochloride Injectable 
(Lot # 7070512 - Phoenix pharmaceutical, Inc. USA).  
The animals that survived the surgery (after a shot of 
Rimadyl (carprofen) NADA # 141-199- Pfizer Animal 
Health, NY, New York, USA) are allowed recovery time 
of at least one week before data collection commences. 
The telemetry device is capable of measuring multiple 
parameters such as systolic blood pressure (SBP), 
diastolic blood pressure (DBP), pulse pressure (PP), 
mean arterial pressure (MAP), heart rate (HR), and 
activity level of the rats simultaneously. During 
recording, animals are allowed to feed and move freely 
in a cage that is placed on a receiver plate connected to 
a computer. Each telemetry device is assigned a code 





Fig. 1: Total serum cholesterol is unchanged in control 
(N=5) and 1% diet (N=5) but there was significantly 
increased rats fed on 2% diet (N=5) compared to control and 
1% diet groups.  The result is significant at p < 0.05. (For 
control and 2% diet); T = 9.729893; P-Value is 1E-05. The 




All experiments repeated several times with similar 
results would have their data presented as the means + 
S.D. The control versus treatment effects 
(hypercholesterolemic group) were compared using 
two-tailed independent Student’s t test, and p values < 




Table 1 Shows low activity pulse pressure in control, 1%, 
and 2% cholesterol diet (hypercholesterolemic) in WKY rats. 
The result is significant at  p < .05 among the control and 2% 
diet animals, but not between control and 1%, or between 1% 
and 2% diet animals at week 2 only. * Indicates significant 













Diet (N=6) * 
 32.10 34.04 28.01 
 37.73 39.42 25.38 
 34.44 35.85 13.58 
 31.78 23.88 30.58 
 - 40.20 15.33 
 - 20.46 30.58 
Mean 34.013 32.308 23.91 
StDev 2.7474 8.244 7.5931 
SEM 1.374 3.366 3.1 
 
Table 2 Shows low activity pulse pressure mean analyses for 
weeks 1 and 2 in 1% and 2% cholesterol diet 
(hypercholesterolemic) variables in WKY rats. Pulse 
pressure in animals fed with 2% cholesterol diet was 
significantly lower than values for 1% cholesterol diet; T-
value is 2.267594, P= .046761. The result is significant at p < 
.05; but not between control and 1% or 2% groups. * 








Diet (N=6) * 
2% Cholesterol 
Diet (N=6) * 
 30.78 34.54 27.22 
 35.79 39.65 27.23 
 34.50 32.17 23.27 
 30.49 37.59 31.51 
 - 39.94 16.47 
 - 22.12 31.51 
Mean 32.89 34.13 26.20 
StDev 2.6592 6.6962 5.6877 
SEM  1.33 2.734 2.322 
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Fig. 2: Low activity systolic (a) and diastolic (b) pressures in WKY rats fed on diet with different levels of cholesterol. There 
was no statistically significant difference  in systolic and diastolic pressure values between control and experimental groups. 
 
 
Fig. 3: Low activity mean arterial pressure (a) and heart rate (b) in WKY rats fed on diet with different levels of cholesterol. 
There was no statistically significant difference in heart rate and mean arterial pressure between controls and  experimental 
groups  
 
Table 3 Shows low activity pulse pressure mean analyses for 
weeks 1 in 1% and 2% cholesterol diet 
(hypercholesterolemic) variables in WKY rats. Pulse 
pressure in animals fed with 2% cholesterol diet was 
significantly lower than values for rats fed on 1% cholesterol 
diet. T-value is 2.247212;  P-Value = 0.048408. The result is 
significant at p < 0.05; but not between control and 1% or 











Diet (N=7) * 
2% Cholesterol 
Diet (N=6) * 
 29.45 35.03 26.43 
 33.84 39.87 29.07 
 34.55 39.33 32.95 
 29.20 40.46 32.44 
 - 39.67 17.60 
 - 37.39 32.44 
 - 23.77 - 
Mean 31.76 36.503 28.488 
StDev 2.8284 5.9175 5.9037 
SE Mean 1.414 2.237 2.41 
Table 4: Shows high activity pulse pressure mean analyses 
for week1 in WKY rats fed with 1% and 2% cholesterol diets  
Pulse pressure in animals fed with 2% cholesterol diet was 
significantly lower than values for rats fed on 1% cholesterol 
diet. T-value is 2.371242; P= 0.03707. The result is 
significant at p < 0.05. * Indicates statistical significance 












Diet (N=7) * 
2% 
Cholesterol 
Diet (N=6) * 
 29.45 35.03 26.43 
 33.84 39.87 29.07 
 34.55 39.33 32.95 
 29.20 40.46 32.44 
 - 39.67 17.60 
 - 37.39 32.44 
 - 23.77 - 
Mean 31.76 36.503 28.488 
StDev 2.8284 5.9175 5.9037 
SE Mean 1.414 2.237 2.41 
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Discussion 
Our study shows that pulse pressure decreases in 
experimental WKY rats with increasing cholesterol 
content in the diet.  It also shows that diet-related pulse 
pressure decrease occurs in both low and high animal 
activities. The telemetry device is capable of measuring 
multiple parameters such as a systolic blood pressure 
(SBP), diastolic blood pressure (DBP), pulse pressure 
(PP), mean arterial pressure (MAP), heart rate (HR), 
and activity level of the rats simultaneously A 
statistically significant difference was only observed in 
pulse pressure between the various experimental 
animals and control. Pulse pressure as a blood pressure 
parameter is an important mortality predictor (Assman 
et al. 2005; Asmar et al. 2003), and among 
hemodialysis (HD) patients, pulse pressure appears to 
be a stronger independent predictor of morbidity and 
mortality than other BP parameters such as systolic 
(SBP), diastolic (DBP), and mean arterial BP (Foley et. 
al. 2002). The pulse pressure is a function of SBP and 
DBP  and is dependent on stroke volume and arterial 
wall elastic properties (Kelly et. al 1992; Alfie et. al. 
1999). Our findings show significant change in pulse 
pressure in the 2% cholesterol fed group compared to 
the 1% cholesterol fed group and control group. One 
would expect a corresponding significant difference in 
systolic pressure and diastolic pressure since the PP is a 
function of SBP and DBP. Although some differences 
did exist among the SBP and DBP between the groups, 
they were however not statistically significant. While it 
is widely acknowledged that high SBP and DBP 
(hypertension) correspond to high PP in hypertension, a 
few findings have equally reported low PP to be 
associated with the high CV mortality rate (Tansel et al 
2010). In mild heart failure, a high PP is probably the 
result of vascular stiffening or decreased aortic 
elasticity, which indicates atherosclerosis, whereas in 
advanced heart failure, low PP chiefly indicates 
decreased cardiac function and an associated adverse 
prognosis (Tansel Y, et. al 2010). Tansel et al. 2010 
also observed low PP in patients who were 
experiencing advanced heart failure. An independent  
association between low PP and CV mortality rate, not 
just in patients with advanced heart failure, but in the 
entire study population have been reported. In addition, 
low PP independently predicts death in ischemic heart 
failure - a novel finding (Tansel et al 2010). Other 
investigators who used PP quartiles or tertiles and 
regression analysis reported that patients in low PP 
quartile (< 35 mm Hg) experienced higher CV 
mortality rates, and the cutoff value of 30 mmHg was 
highly predictive of CV death (Domanski et. al. 1999; 
Aronson & Burger 2004;  Voors et. al. 2005;  Petrie et. 
al. 2009).   
In some cases during our study, PP < 23mmHg were 
recorded. Although our group does not know of any 
previous report on investigation of cardiac function 
following induced-hypercholesterolemia in 
experimental animals, our results are indicative of 
deteriorated cardiac function.  Since our findings did 
not show a significant increase in SBP and DBP, it is 
reasonable to speculate that the high cholesterol diet in 
this investigation negatively impacted heart function 
rather than the vascular function. As the cardiac and 
vascular function closely influence each other, the 
overall CV well-being of an individual heavily depends 
on both.  
One interesting observation of this study is that the 1% 
coloesterol diet-fed rats showed indices close to normal 
cardiac function in some cases compared to the control 
and the 2% groups. Therefore, it remains to be 
elucidated if elevated cholesterol to a certain degree 
confers some advantages on cardiovascular function. 
The entire process involved in the small animal surgery 
and post surgery events are very delicate and 
constitutes an impediment to generating high sample 
size; we therefore consider sample size a major 
weakness of our study. The telemetry technique 
employed is this study allows the animals to remain 
free while the data were remotely collected; this is 
considered unique and produces data that are reliable 
for cardiovascular investigations. 
 
In conclusion, we report that a decline in pulse pressure 
in induced-hypercholesterolemic animals is indicative 
of poor cardiovascular function. Based on our findings,  
it would be safe to assert that a high cholesterol diet 
may negatively impact the cardiac function more than 
the vascular function. A further investigation on 
changes in CV that would involve either human 
subjects that have been diagnosed with 
hypercholesterolemia or a more robust sample size of 
the experimental animals may shed more light on the 
effect of hypercholesterolemia on specific CV indices 
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